Anyone who breathes can develop COPD. The world is at risk, and chronic respiratory diseases must be treated as both a global ...

A tool combining CV risk score (CVRS) and coronary artery calcium score (CACS) facilitates stratification of patients with COPD at risk for MACE.

The COPD Action Alliance applauds Governor Bill Lee for proclaiming November as Chronic Obstructive Pulmonary Disease (COPD) Awareness Month in Tennessee, recognizing the urgent need for greater ...

Discover how chronic respiratory failure increases heart disease risk in COPD patients. Learn why early cardiovascular ...

As millions of COPD cases remain undiagnosed, Europe must make early detection a top health priority to strengthen health systems ...

On Oct. 20, Chicago Fire Department firefighters had the opportunity to get screened for COPD at Station 18, thanks to a ...

Brensocatib, a DPP1 inhibitor, is the first FDA-approved therapy for non-cystic fibrosis bronchiectasis, showing significant clinical and structural benefits. The ASPEN trial demonstrated that ...

Generation Z — often represented and referred to those born between the mid-1990s and 2012 — are the ones to grow up ...

With national-scale validation in Europe, clinical adoption across top-tier U.S. institutions, and 2.5 million cases ...

Regardless of blood eosinophil count threshold, adults with COPD and an eosinophilic phenotype experienced significantly fewer moderate/severe exacerbations in a year with mepolizumab vs. placebo, ...

Health Ministry directs States to set up CHEST Clinics to combat pollution-linked heart and lung diseases. Clinics will ...